<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Younes</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gopal</surname>
    <given-names>AK</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>SE</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma</article-title>
  <source>J Clin Oncol</source>
  <year>2012</year>
  <volume>30</volume>
  <fpage>2183</fpage>
  <lpage>2189</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2011.38.0410</pub-id>
  <?supplied-pmid 22454421?>
  <pub-id pub-id-type="pmid">22454421</pub-id>
 </element-citation>
</ref>
